These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 23791367

  • 1. Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
    Bhasin D, Chettiar SN, Etter JP, Mok M, Li PK.
    Bioorg Med Chem; 2013 Aug 01; 21(15):4662-9. PubMed ID: 23791367
    [Abstract] [Full Text] [Related]

  • 2. Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones.
    Bhasin D, Etter JP, Chettiar SN, Mok M, Li PK.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6864-7. PubMed ID: 24176397
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
    Mallavadhani UV, Prasad CV, Shrivastava S, Naidu VG.
    Eur J Med Chem; 2014 Aug 18; 83():84-91. PubMed ID: 24953027
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition.
    Li N, Ou J, Bao N, Chen C, Shi Z, Chen L, Sun J.
    Bioorg Chem; 2020 Nov 18; 104():104208. PubMed ID: 32919131
    [Abstract] [Full Text] [Related]

  • 5. Discovery and cellular stress pathway analysis of 1,4-naphthoquinone derivatives with novel, highly potent broad-spectrum anticancer activity.
    Ghosh SK, Ganta A, Spanjaard RA.
    J Biomed Sci; 2018 Feb 08; 25(1):12. PubMed ID: 29422060
    [Abstract] [Full Text] [Related]

  • 6. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
    Bao N, Ou J, Xu M, Guan F, Shi W, Sun J, Chen L.
    Eur J Med Chem; 2017 Sep 08; 137():88-95. PubMed ID: 28558333
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and anticancer activity of 2-amidomethoxy-1,4-naphthoquinones and its conjugates with Biotin/polyamine.
    Manickam M, Boggu PR, Pillaiyar T, Nam YJ, Abdullah M, Lee SJ, Kang JS, Jung SH.
    Bioorg Med Chem Lett; 2021 Jan 01; 31():127685. PubMed ID: 33197549
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
    Zhang Q, Dong J, Cui J, Huang G, Meng Q, Li S.
    Chem Pharm Bull (Tokyo); 2018 Jan 01; 66(6):612-619. PubMed ID: 29863062
    [Abstract] [Full Text] [Related]

  • 9. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
    Dandawate P, Ahmad A, Deshpande J, Swamy KV, Khan EM, Khetmalas M, Padhye S, Sarkar F.
    Bioorg Med Chem Lett; 2014 Jul 01; 24(13):2900-4. PubMed ID: 24835626
    [Abstract] [Full Text] [Related]

  • 10. Design, Synthesis, Biological Evaluation, and Antioxidant and Cytotoxic Activity of Heteroatom-Substituted 1,4-Naphtho- and Benzoquinones.
    Deniz NG, Ibis C, Gokmen Z, Stasevych M, Novikov V, Komarovska-Porokhnyavets O, Ozyurek M, Guclu K, Karakas D, Ulukaya E.
    Chem Pharm Bull (Tokyo); 2015 Jul 01; 63(12):1029-39. PubMed ID: 26633024
    [Abstract] [Full Text] [Related]

  • 11. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.
    Löcken H, Clamor C, Müller K.
    J Nat Prod; 2018 Jul 27; 81(7):1636-1644. PubMed ID: 30003778
    [Abstract] [Full Text] [Related]

  • 12. Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors.
    Xu K, Xiao Z, Tang YB, Huang L, Chen CH, Ohkoshi E, Lee KH.
    Bioorg Med Chem Lett; 2012 Apr 15; 22(8):2772-4. PubMed ID: 22437113
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform.
    Ning X, Qi H, Li R, Jin Y, McNutt MA, Yin Y.
    J Enzyme Inhib Med Chem; 2018 Dec 15; 33(1):126-129. PubMed ID: 29185365
    [Abstract] [Full Text] [Related]

  • 14. Investigation of chemical reactivity of 2-alkoxy-1,4-naphthoquinones and their anticancer activity.
    Manickam M, Boggu PR, Cho J, Nam YJ, Lee SJ, Jung SH.
    Bioorg Med Chem Lett; 2018 Jun 15; 28(11):2023-2028. PubMed ID: 29735338
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.
    Prachayasittikul V, Pingaew R, Worachartcheewan A, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittikul V.
    Eur J Med Chem; 2014 Sep 12; 84():247-63. PubMed ID: 25019480
    [Abstract] [Full Text] [Related]

  • 17. Structure activity relationship of plumbagin in BRCA1 related cancer cells.
    K A T, T R, G R, K C S, Nair RS, G S, Banerji A, Somasundaram V, Srinivas P.
    Mol Carcinog; 2013 May 12; 52(5):392-403. PubMed ID: 22290577
    [Abstract] [Full Text] [Related]

  • 18. First synthesis and anticancer activity of novel naphthoquinone amides.
    Pradidphol N, Kongkathip N, Sittikul P, Boonyalai N, Kongkathip B.
    Eur J Med Chem; 2012 Mar 12; 49():253-70. PubMed ID: 22280818
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
    Aly AA, El-Sheref EM, Bakheet MEM, Mourad MAE, Brown AB, Bräse S, Nieger M, Ibrahim MAA.
    Bioorg Chem; 2018 Dec 12; 81():700-712. PubMed ID: 30268050
    [Abstract] [Full Text] [Related]

  • 20. Antimutagenic and antioxidant properties of plumbagin and other naphthoquinones.
    Kumar S, Gautam S, Sharma A.
    Mutat Res; 2013 Jul 04; 755(1):30-41. PubMed ID: 23688616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.